Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
venture capital (VC)
Biotech
Fierce Biotech Fundraising Tracker: Braveheart, Azalea & more
Welcome to Fierce Biotech's Fundraising Tracker for 2025.
Gabrielle Masson
,
Darren Incorvaia
,
James Waldron
Nov 5, 2025 6:33am
Neok exits stealth with $75M to take bispecific ADCs into clinic
Nov 4, 2025 7:00am
Italian biotech raises $141M series B to fund eye gene therapies
Nov 3, 2025 3:00am
Electra shines with $183M fundraise for rare disease trial
Oct 22, 2025 8:26am
British biotech elevates with $70M and midstage arthritis asset
Oct 21, 2025 7:01pm
PE dealmaking, exit counts on the rise in Q3: PitchBook
Oct 20, 2025 5:05pm